Comparative analysis of immunogenicity between first-dose measles-mumps-rubella (MMR) vaccine administration and combined MMR-rotavirus vaccination
- PMID: 40340635
- PMCID: PMC12068349
- DOI: 10.1080/21645515.2025.2484884
Comparative analysis of immunogenicity between first-dose measles-mumps-rubella (MMR) vaccine administration and combined MMR-rotavirus vaccination
Abstract
This study compared the immunogenicity of the measles-mumps-rubella (MMR) vaccine when administered alone versus when co-administered with the rotavirus vaccine in infants aged 8-9 months. In this prospective cohort study, 1,198 infants were enrolled: 800 received combined MMR and rotavirus vaccines (experimental group), while 398 received the MMR vaccine alone (control group). A Hurdle Gamma model analyzed vaccination impact on antibody levels in both groups and the correlation between antibody responses. Geometric mean concentrations of measles, rubella, and mumps IgG antibodies increased significantly in both groups after vaccination. The experimental group demonstrated 209-fold, 25-fold, and 12-fold increases, respectively, with comparable increases in the control group. Hurdle Gamma model analysis revealed significant positive effects of vaccination on all three antibody levels, with no significant differences between MMR-rotavirus combined vaccination and MMR vaccination alone. Random effects analysis showed strong negative correlations for measles and rubella IgG antibodies (correlation coefficients: -1.00 and -0.99, respectively) and a moderate negative correlation for mumps IgG antibodies (correlation coefficient: -0.56). This study represents the first application of a Hurdle Gamma model to compare immunogenicity between standalone MMR vaccination and combined MMR-rotavirus vaccination. The results demonstrate equivalent MMR antibody responses between these two vaccination approaches.
Keywords: MMR vaccine; immunogenicity; rotavirus vaccine; separate vaccination vs. combined vaccination.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Similar articles
-
Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.Vaccine. 2002 Dec 13;21(3-4):281-9. doi: 10.1016/s0264-410x(02)00459-0. Vaccine. 2002. PMID: 12450703 Clinical Trial.
-
A new measles mumps rubella (MMR) vaccine: a randomized comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed children.Int J Infect Dis. 2002 Sep;6(3):202-9. doi: 10.1016/s1201-9712(02)90112-8. Int J Infect Dis. 2002. PMID: 12718836 Clinical Trial.
-
Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study.Hum Vaccin Immunother. 2018;14(11):2624-2631. doi: 10.1080/21645515.2018.1489186. Epub 2018 Jul 12. Hum Vaccin Immunother. 2018. PMID: 29902133 Free PMC article. Clinical Trial.
-
Vaccines for measles, mumps, rubella, and varicella in children.Cochrane Database Syst Rev. 2020 Apr 20;4(4):CD004407. doi: 10.1002/14651858.CD004407.pub4. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Nov 22;11:CD004407. doi: 10.1002/14651858.CD004407.pub5. PMID: 32309885 Free PMC article. Updated.
-
Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella.Drugs. 2003;63(19):2107-26. doi: 10.2165/00003495-200363190-00012. Drugs. 2003. PMID: 12962524 Review.
References
-
- Association CPM. Expert consensus on immunological prevention of rotavirus gastroenteritis in children (2020 edition). Chin J Epidemiol. 2021;42:44–57. doi: 10.3760/cma.j.cn112150-20231220-00472. - DOI
-
- Liu Y, An J, Jiao YZ, Liang XF, Zhang XS. Risk analysis of simple febrile seizures within 30 days after measles-mumps-rubella combined live attenuated vaccine in children under 12 years old in real world. Chin J Pharmacovigil. 2024;21:805. doi: 10.1503/cmaj.140078. - DOI
-
- Wang R, Sun XR, Yang F, Wang Q, Wang L, Wei S. Health economic evaluation of simultaneous administration of domestic oral rotavirus vaccine and immunization program vaccines in children under 5 years old. Chin J Dis Control. 2024;28:976–981. doi: 10.1016/j.vaccine.2020.05.035. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources